首页> 外文OA文献 >Economic Evaluation of Bivalirudin With or Without Glycoprotein IIb/IIIa Inhibition Versus Heparin With Routine Glycoprotein IIb/IIIa Inhibition for Early Invasive Management of Acute Coronary Syndromes

【2h】

Economic Evaluation of Bivalirudin With or Without Glycoprotein IIb/IIIa Inhibition Versus Heparin With Routine Glycoprotein IIb/IIIa Inhibition for Early Invasive Management of Acute Coronary Syndromes

机译：比伐卢定有或无糖蛋白IIb / IIIa抑制与肝素和常规糖蛋白IIb / IIIa抑制相比对早期急性冠脉综合征的侵入性治疗的经济评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Pinto Duane S.; Stone Gregg W.; Shi Chunxue; Dunn Elizabeth S.; Reynolds Matthew R.; York Meghan; Walczak Joshua; Berezin Ronna H.; Mehran Roxana; McLaurin Brent T.; Cox David A.; Ohman E. Magnus; Lincoff A. Michael; Cohen David J.;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. [J] . Pinto DS, Stone GW, Shi C, Journal of the American College of Cardiology . 2008,第22期

机译：对具有或不具有糖蛋白IIb / IIIa抑制作用的比伐卢定与常规糖蛋白IIb / IIIa抑制作用的肝素进行急性冠脉综合征的早期侵入性治疗的经济评价。
2. Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary grafts (the ACUITY trial investigators). [J] . Kumar D, Dangas G, Mehran R, The American Journal of Cardiology . 2010,第7期

机译：比伐卢定与比伐卢定加糖蛋白IIb / IIIa抑制剂与肝素加糖蛋白IIb / IIIa抑制剂在急性冠脉综合征患者中进行了经皮介入治疗的大隐静脉主动脉冠状动脉狭窄的比较（ACUITY试验研究者）。
3. Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome [J] . Navarese Eliano Pio, Schulze Volker, Andreotti Felicita, JACC. Cardiovascular interventions . 2015,第1期

机译：比伐卢定与肝素联合或不联合常规糖蛋白IIb / IIIa抑制剂对急性冠脉综合征患者安全性和有效性的综合荟萃分析
4. The Long-Term Clinical Outcomes of Platelet Glycoprotein Ilb/IIIa Inhibitor Combined with Low Molecular Weight Heparin in Patients with Acute Coronary Syndrome [C] . J.H. Kim, M.H. Jeong, Y.J. Hong, International Congress on Thrombosis . 2004

机译：血小板糖蛋白ILB / IIIa抑制剂的长期临床结果与急性冠状动脉综合征患者低分子量肝素联合
5. Bivalirudin versus heparin in percutaneous coronary intervention—a systematic review and meta-analysis of randomized trials stratified by adjunctive glycoprotein IIb/IIIa strategy [O] . Mahesh Anantha-Narayanan, Dixitha Anugula, Nagarjuna R. Gujjula, 2018

机译：比伐卢定与肝素在经皮冠状动脉介入治疗中的系统评价及荟萃分析以糖蛋白IIb / IIIa辅助策略分层
6. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention Results from the REPLACE-2 trial [O] . Cohen David J., Lincoff A. Michael, Lavelle Tara A., 2004

机译：对比伐卢定进行临时性糖蛋白IIB / IIIA抑制与常规肝素对常规糖蛋白IIB / IIIA抑制的经皮冠状动脉介入治疗的经济性评估REPLACE-2试验的结果

Economic Evaluation of Bivalirudin With or Without Glycoprotein IIb/IIIa Inhibition Versus Heparin With Routine Glycoprotein IIb/IIIa Inhibition for Early Invasive Management of Acute Coronary Syndromes

著录项

引文网络

相似文献

相关主题

期刊订阅